|
Fame Medical Group Takeover Completed Successfully
aap today completed the acquisition of all shares in the Dutch FAME Holding B.V. Group and its subsidiaries with the commercial register entry.
The capital increase by a contribution in kind agreed at the extraordinary general meeting of aap Implantate AG held on February 15, 2007 was today entered into the commercial register. Lawsuits filed by individual shareholders had delayed the entry. aap thereupon embarked on fast track proceedings, an option available since 2006 that is intended to enhance the legal and procedural security of companies affected by lawsuits filed in connection with shareholders’ meetings.
The register entry increases aap Implantate AG’s capital stock by EUR 8,448,999.00 to EUR 25,347,156.00, divided into 25,347,156 individual share certificates.
Listing of the new shares for stock market trading is planned for the weeks ahead. Due to contractual provisions 50 percent of the new shares are subject to a 12-month lock-up period after listing.
For further information, please contact: aap Implantate AG | | Lorenzweg 5 | | D-12099 Berlin | | X | | Oliver Bielenstein | Nanette Hüdepohl | | Director/CFO | Investor & Public Relations | Tel.: +49 30 750 19 - 140 | Tel.: +49 30 75019 - 133 | Fax: +49 30 750 19 - 290 | Fax: +49 30 75019 - 290 | | X | | WKN 506660, ISIN DE0005066609 | | Prime Standard/Regulated Market | | Traded at all German Stock Exchanges |
|